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Role of aPKC Isoforms and Their Binding Partners
Par3 and Par6 in Epidermal Barrier Formation
Iris Helfrich1, Annika Schmitz1, Paola Zigrino2, Christian Michels1, Ingo Haase1,2, Andre´ le Bivic3,
Michael Leitges4 and Carien M. Niessen1
The skin water barrier, essential for terrestrial life, is formed by a multilayered stratifying epithelium, which
shows a polarized distribution of both differentiation and intercellular junction markers. Recently, several
reports showed the crucial importance of tight junctions for the in vivo water barrier function of the skin. In
simple epithelial cells, intercellular junction formation is closely coupled to the establishment of polarity.
However, if and how polarity proteins contribute to epidermal differentiation and junction formation is not yet
known. Here, we have characterized the localization and isoform expression of the polarity protein atypical PKC
(aPKC) and its binding partners Par3 and Par6 in epidermis and primary keratinocytes of mice. Their distribution
is only partially overlapping in the granular layer, the site of functional tight junctions, suggesting that next to a
common Par3/Par6/aPKC function they also may have functions independent of each other. Both aPKCz and
aPKCi/l, are expressed in the epidermis but only aPKCi/l showed a strong enrichment in the junctions,
suggesting that this aPKC isoform is important for epidermal tight junction function. Indeed, inhibition of aPKC
function showed that endogenous aPKC is crucial for in vitro barrier function and this required the presence of
both the Par3 and Par6 binding sites.
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INTRODUCTION
The outer layer of the skin, the epidermis, forms the most
direct contact of the organism with the outside world. As
such, it supplies the organism with a barrier against
detrimental influences from the outside, such as adverse
chemicals or pathogens. It also provides a barrier to the inside
by preventing the unnecessary loss of water and small
nutrients, thus protecting the organism from dehydration. The
epidermis is a stratifying, multilayered epithelium, in which
each layer has obtained specialized properties that ultimately
contribute to the formation of such a two-way barrier.
Importantly, the barrier is not static but requires continuous
renewal to maintain proper protection. This is achieved by a
tightly controlled balance between proliferation and differ-
entiation. The basal layer contains the proliferating cells from
which the differentiated suprabasal layers are derived (Watt,
2001; Fuchs and Raghavan, 2002). In many skin diseases
disturbances in the barrier are often associated with altera-
tions in this balance and with inflammation, although it is
unclear what is cause and consequence.
Cell polarity is a fundamental property of cells and is
crucial for the establishment of anterior–posterior embryonal
axis set-up, morphogenesis, differentiation, and cell identity
by regulating asymmetric cell division, directed migration,
axonal polarity, control of proliferation, and apical-basolat-
eral polarity in simple epithelia (Nelson, 2003). The atypical
PKC (aPKC) is a key player in the generation of almost all
forms of polarity (Henrique and Schweisguth, 2003). aPKC
forms a complex with Par6 and Par3, proteins initially
identified in the set-up of anterior/posterior polarity in
Caenorhabditis elegans (Kemphues et al., 1988). This
complex is essential for the formation of tight junctions in
simple epithelial cells (Ohno, 2001; Macara, 2004).
Both Par6 and Par3 belong to the PDZ family of adaptor
proteins. Par6 appears to be necessary for activation of aPKC,
by connecting aPKC to the GTP bound form of the small
GTPases Rac and Cdc42 (Joberty et al., 2000; Lin et al.,
2000). This results in a conformational change in Par6,
allowing phosphorylation and subsequent activation of aPKC
(Garrard et al., 2003). Par3 is thought to be a scaffolding
protein necessary for the proper recruitment of the Par6/aPKC
to sites where its activity is required. For example, Par3 binds
directly to junctional adhesion molecules (JAMs), and this
recruits it to the tight junctions in simple epithelial cells
(Ebnet et al., 2001). In addition, Par6 may also allow for the
placement of the complex to membranes by interaction with
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Pals1, which connects it to the Crumbs (Crb) transmembrane
proteins (Hurd et al., 2003), or by direct interaction with Crb3
(Lemmers et al., 2004).
Next to its role in polarity aPKC may also play a role in
inflammatory responses by regulating NF-kB (Moscat et al., 2006)
and in metabolic regulation of tissues because insulin receptor
activation stimulates aPKC kinase activity (Farese, 2002).
Two types of aPKC exist, aPKCzeta (aPKCz) and aPKCiota/
lambda (aPKCi/l), which are highly related but encoded by
separate genes (Suzuki et al., 2003). At present it is unclear if
both aPKCs are functionally redundant and thus can mediate
the various aPKC functions or if different roles are performed
by either one of the aPKCs.
The epidermis is not a classical polarized epithelium, such
as intestinal epithelium, which has a clear apical and baso-
lateral membrane domain separated by the apical junctional
complex. Nevertheless, the epidermis shows polarization in a
broader sense, such that specific layers of the epidermis not
only express a unique set of differentiation but also junctional
markers (Watt, 2001; Getsios et al., 2004). Recently, it was
shown that asymmetric cell division does occur in the
epidermis, thus contributing to stem cell maintenance and
the balance between basal proliferation and differentiation
(Lechler and Fuchs, 2005). In cells undergoing asymmetric
cell division, aPKC is targeted to the apical membrane.
However, presently it is unknown how polarity is achieved in
stratifying, multilayered epithelia and if central players in
other forms of polarity, like for example, aPKC and its binding
partners Par3 and Par6, contribute to the formation, main-
tenance, and function of stratifying epithelia.
To obtain further insight into the role of the aPKC/Par3/
Par6 complex in stratifying epithelia we have characterized
its tissue distribution and aPKC isoform expression in mouse
epidermis under normal homeostasis and wound healing.
In addition, we have characterized their in vitro expression
pattern in mouse keratinocytes under undifferentiated and
differentiated conditions. Finally we show that in vitro
inhibition of aPKC in keratinocytes results in impaired barrier
formation.
RESULTS
Very little is known about the role of the aPKC/Par3/Par6
polarity complex in multilayered epithelia. To characterize
this complex in squamous differentiating epithelia the
distribution of aPKC, Par3, and Par6 was examined in
newborn mouse skin. The predominant localization of aPKC
was found in basal keratinocyte at the dermal/epidermal
junction, using an antibody that recognizes both isoforms of
aPKC, aPKCz, and aPKCi/l (Figure 1a). This antibody also
showed a faint positive signal in the nuclei of the basal cells.
Using an antibody that potentially recognizes all three Par3
isoforms (180, 150, and 100 kDa, which are generated by
alternative splicing), Par3 was mostly found in the cytoplasm
of basal cells, whereas in suprabasal layers it was predomi-
nantly localized to sites of cell–cell contact (Figure 1a,
(Tunggal et al., 2005). A somewhat different pattern
was observed using a Par3 antiserum that recognizes
predominantly the smallest, 100 kDa, isoform (Figure 1a).
This showed positive staining in the granular layer, where it
seemed to be mostly localized in cytoplasmic granules and,
although weakly, on the cell membrane. Interestingly,
antibodies to Par6 showed a relatively similar distribution
as the Par3 100 kDa isoform. It was predominantly localized
to the granular layer, where it was enriched in the cytoplasm.
In simple epithelial cells the Par3/Par6/aPKC complex is
localized to tight junctions, and it can be recruited to these
structures either by the interaction of Par3 with JAM-1 (Ebnet
et al., 2001), or by binding of Par6 to the Crb complex (Hurd
et al., 2003; Lemmers et al., 2004). We therefore also
examined the distribution of the transmembrane molecules
JAM-1 and Crb2 and Crb3. Both JAM-1 and Crb2 are
enriched on the cell membrane in suprabasal layers (Figure
1b). In basal cells JAM-1 appears mostly diffuse whereas Crb2
staining is mostly negative. Crb3 showed a strong diffuse
staining in basal cells with some enrichment at the basal
side of these cells. In the stratum spinosum, Crb3 localization
was predominantly perinuclear whereas in the stratum gra-
nulosum faint membrane localization could be observed
(Figure 1b).
Regulation of expression by calcium-mediated differentiation
The differential distribution observed for the Par3/Par6/aPKC
proteins suggested that protein expression might be affected
by differentiation of the keratinocytes. To examine if
differentiation indeed affects protein expression, mouse
keratinocytes were switched from low calcium containing
medium (o50 mM) to high Ca2þ (1.8 mM) containing medium
and incubated for different time points. High calcium does
not only induce differentiation of keratinocytes but also
permits the formation of intercellular junctions. Keratinocytes
express all three Par3 isoforms (Lin et al., 2000), albeit it that
the 180 and 100 kDa are more predominant than the 150 kDa
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Figure 1. Localization of polarity proteins in the skin of newborn mice.
(a) Localization of components of the Par3/Par6/aPKC complex. (b)
Localization of the transmembrane proteins Crb2, Crb3, and JAM-1.
Cryosections of newborn skin were fixed with 4% paraformaldehyde,
incubated using the appropriate antibodies and stained with Alexa 488-
conjugated secondary antibodies (green). Nuclei were counterstained with
propidium iodide (red). Insets in (b) show higher magnification.
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isoform (Figure 2). Both Par3 and aPKC are already present in
substantial amounts in undifferentiated keratinocytes (Fig-
ure 2, 0 hour Ca2þ ), even though junctions are not formed
under these conditions. Importantly, switching to high levels
of Ca2þ did not substantially upregulate overall protein
levels, indicating that regulation of Par3 and aPKC expression
is largely independent of junction formation and/or differ-
entiation (Figure 2). However, differentiation may affect
relative levels of Par3 isoform expression as the 150 kDa
isoform is upregulated after 3 and 24 hours of high calcium
treatment (Figure 2). Differentiation did not significantly alter
expression levels of the small GTPases Cdc42 and Rac, which
can both activate the Par3/Par6/aPKC complex (Joberty et al.,
2000; Lin et al., 2000), and the Par3-binding molecule JAM-1
(Figure 2).
The situation was different for Par6. Although some Par6
was present in non-differentiated keratinocytes, expression
was increased after 3 and 24 hours of Ca2þ -induced differ-
entiation (Figure 2). Surprisingly, after 48 hours of calcium
treatment Par6 levels decreased to a level comparable to
that of undifferentiated keratinocytes.
Both aPKCf and aPKCi/k are expressed in skin
At present it is unclear if the two isotypes of aPKC, aPKCz,
and aPKCi/l, have separate or overlapping function. To
examine which aPKCs are expressed in skin, reverse
transcription PCR (RT-PCR) was performed. Both aPKCz and
aPKCi/l RNA were found in total skin (Figure 3a). Upon
separation of the epidermis and dermis, expression of both
forms was found in the epidermis whereas only a very faint
signal could be detected in dermis. A similar result was found
in vitro using RNA isolated from either keratinocytes or
fibroblasts. Keratinocytes express both aPKC isotypes
whereas fibroblasts showed little to no signal (Figure 3a).
We next examined if RNA expression of the two isotypes is
sensitive to Ca2þ -induced differentiation. For both aPKC
types no discernable regulation of expression levels was
observed (Figure 3b).
To examine if there are differences in protein expression of
the two different aPKCs, antibodies were generated using
antigens that are specific for either aPKCz or aPKCi/l.
Western blot analysis revealed that the aPKCi/l antiserum
specifically recognized a protein at the expected molecu-
lar weight of 70 kDa of aPKCi/l (Figure 4a), in addition
to a smaller molecular weight protein of around 50 kDa,
the identity of which is not known. Similar to the RNA
data, Ca2þ -induced differentiation did not affect the steady-
state levels of aPKCi/l. The anti-aPKCz antibodies also
recognized a protein of the expected molecular weight,
the levels of which were slightly upregulated upon differ-
entiation (Figure 4a).
Using the specific antibodies we examined the distribution
of aPKCz and aPKCi/l in the epidermis. An intense staining
was seen for aPKCi/l in the cytoplasm of basal cells. These
cells also showed faint nuclear localization. However, in the
suprabasal cells localization at the membrane was the
predominant pattern for aPKCi/l (Figure 4b). Interestingly,
in the granular layer a highly concentrated staining was
observed at lateral intercellular borders, which is reminiscent
of the distribution of several tight junctional markers in the
skin (Tunggal et al., 2005). The pattern was different for
aPKCz. A strong cytosolic signal, in addition to weak nuclear
staining, was observed in basal cells, whereas the suprabasal
layers were only weakly positive (Figure 4b).
Localization of the Par3/par6/aPKC complex in differentiated
keratinocytes
The distribution of aPKCi/l and Par3 on cell membranes of
the suprabasal epidermal layers suggested that they are
incorporated into intercellular junctions. To examine the time
frame after which the Par3/Par6/aPKC complex is recruited to
intercellular junctions, mouse keratinocytes were differen-
tiated with medium containing high Ca2þ concentration
(1.8 mM) for different time points. Staining was predominantly
cytosolic under non-differentiating conditions or after 3
hours of calcium-induced differentiation (results not shown),
a time point at which a marker for tight junctions (occludin,
Figure 5b) is already recruited to the membrane and found at
sites of initial contacts. After 24 hours of Ca2þ -induced
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Figure 2. Expression of Par3/Par6/aPKC complex components and
associated proteins in keratinocytes upon differentiation. Primary mouse
keratinocytes were differentiated with 1.8 mM Ca2þ for the indicated time
points after which cells were lysed. Equal amounts of proteins were separated
by SDS-PAGE and immunoblotted for the indicated proteins.
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Figure 3. RNA expression of aPKC isotypes in skin and primary
keratinocytes. (a) RT-PCR analysis for aPKCz and aPKCi/l in murine skin or
cells. Lung RNA was used as a positive control. (b) RT-PCR analysis for aPKCz
and aPKCi/l in non-differentiated (0 hour) and differentiated keratinocytes.
Cells were differentiated with 1.8 mM Ca2þ for the indicated times. PCR was
carried out using primers specific for either aPKCz or aPKCi/l. -ct: without
reverse transcriptase.
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differentiation, occludin (Figure 7b), and ZO-1(not shown)
were predominantly found at junctional structures. At this
time, in some cells, Par3 was recruited to these ZO-1
containing junctions whereas no Par6 or aPKC was found at
the membrane (results not shown). This suggests that Par3 is
recruited to junctions before the other components. Indeed,
Par3 was found at the membrane in all cells after 48 hours
(Figure 5a), where it colocalized with ZO-1. Nevertheless,
cytosolic staining was still observed, indicating that not all
Par3 is recruited to the junctions. Some Par6 and aPKC was
recruited to the membrane in some cells but only after
prolonged differentiation (48–72 hours) (Figure 5a), even
though robust tight junctions are formed at those points, as
judged by ZO-1 (Figure 5) and occludin staining (Figure 7b).
Membrane association was more obvious when we used
the aPKCi/l-specific antibody in comparison to staining
with the aPKC antibody that recognizes both isotypes
(Figure 5a). Interestingly, strong membrane staining was
seen when using an antibody that recognizes phosphorylated
Hours Ca2+
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Figure 4. Expression and localization of aPKC isotypes in newborn skin
and primary keratinocytes. (a) aPKCz or aPKCi/l protein expression in
non-differentiated keratinocytes (0 h) and keratinocytes differentiated
with Ca2þ for the indicated time points. Equal amounts of proteins were
separated by SDS-PAGE and immunoblotted with antibodies specific for
aPKC z or aPKCi/l. (b) Expression of aPKCi/l or aPKCz in newborn mouse
skin. Cryosections were stained with the specific aPKCz or aPKCi/l antibodies
using Alexa 488-labeled secondary antibodies. Nuclei were counterstained
with propidium iodide. The arrowhead points out aPKCz expression at the
membranes in the granular layer. Insets show areas with higher magnification.
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Figure 5. Localization and recruitment of polarity proteins to junctions in
differentiated primary keratinocytes. Immunohistochemistry for (a) Par3,
Par6, aPKC, aPKCi/l, phospho-aPKC (P-aPKC), and ZO-1 in primary
keratinocytes after differentiation with Ca2þ for 48 hours and (b) Crb2, Crb3,
JAM-1, and ZO-1 in primary keratinocytes 72 hours after Ca2þ induction.
Cells were fixed with ice-cold methanol for 10 minutes at 41C, stained with
the appropriate antibodies and secondary antibodies labeled with Alexa 488.
Arrowheads: expression at cell–cell contacts.
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Figure 6. Localization of Par3/Par6/aPKC complex components at different
stages during wound healing. (a–c) Wounds stained for hematoxylin/eosin,
(d–f) aPKC, (g–i) Par3 and (j–l) Par6 at days 5, 7, and 11 after wounding.
Cryosections were stained with the specific antibodies using Alexa 488-
labeled secondary antibodies. Nuclei were counterstained with propidium
iodide. Left inset in (d) shows staining for aPKC in normal adult skin. Other
insets are higher magnification. Bar in inset of (d) also applies to insets in
(f, h, i, and l). D and k: wound edge,$: new epithelial sheet,r: wound scab.
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forms of both aPKCs, indicative of the active form (Figure 5a).
Most staining for Par6 remained cytoplasmic after 48 hours
(Figure 5a).
A similar result was found for both Crb2 and Crb3.
Although weak membrane association was observed for both
Crb2 and Crb3, most of their localization was cytoplasmic 48
or 72 hours after the calcium switch (Figure 5b). In contrast,
JAM-1 was mostly found at the membrane (Figure 5b), where
it colocalized with ZO-1.
Distribution in wound healing
As polarity is altered or locally lost during wound healing, we
were interested in assessing the distribution of the Par3/Par6/
aPKC complex during different stages of wounding. In adult
murine skin the distribution of aPKC, using an antibody that
recognizes both isoforms, is mostly cytosolic and nuclear (left
inset in Figure 6d) but after 5 days, aPKC accumulated at the
basal side of the basal cells in the hyperproliferative area
(Figure 6d, right inset), similar to its distribution in newborn
skin (Figure 1a). This epidermal–dermal distribution in basal
cells was observed in the wound margins but disappeared in
basal cells of the newly re-epithelialized skin. In addition, a
strong nuclear staining was also observed. A similar staining
pattern was observed in day 7 old wounds (Figure 6e).
However, after 11 days the basal localization of aPKC in
basal cells had completely disappeared coinciding with
reduced hyperproliferation (Figure 6f). Instead, its distribution
resembled that seen in adult murine skin.
Par3 is found at the cell membrane in suprabasal layers
(Figure 6g), similar to its localization in newborn skin. This
distribution did not significantly change upon wounding
(Figure 6h and i). Par3 was still associated with the cell
membrane, both in the wound margin and in the newly
formed epidermis (Figure 6) after 5 and 7 days of wounding.
In contrast, Par6 was redistributed after 5 days of
wounding. The vesicle like staining in the granular layer
found in normal skin (Figure 1) was largely absent and Par6
appeared to have a more cytosolic localization in the most
upper layers (Figure 6j). In addition, an intense cytoplasmic
staining was found in the basal layer both of the hyper-
proliferative domain and the new epithelial sheet. This basal
Par6 localization was largely gone after 7 days of wounding.
At this point the vesicle like staining in the granular layer
was again the most predominant staining (Figure 6k). This
pattern remained unaltered at day 11 after wounding, when
re-epithelialization was complete (Figure 6l).
aPKC contributes to in vitro barrier formation
To test if aPKC is important for epidermal barrier function, a
non-invasive in vitro barrier formation assay was established
for primary keratinocytes, which was adapted from trans-
epithelial resistance (TER) measurements, often used for
simple epithelial cells (Matter and Balda, 2003). This assay
indirectly assesses tight junction formation and function.
Keratinocytes are switched to high calcium medium (1.8 mM)
to induce differentiation and the formation of intercellular
junctions and TER is measured over time. An increase in TER
indicates the formation of an epithelial barrier. Indeed upon
induction of differentiation, primary mouse keratinocytes
increased their trans epithelial resistance over time with high
TER at 48 hours of Ca2þ treatment (Figure 7a). This increase
coincides with translocation of occludin (Figure 7b) ZO-1
(Figure 6) and claudin-1 (not shown) to sites of cell–cell
contacts. At 24 hours of Ca2þ treatment, occludin was found
in junctional structures at the membrane (Figure 7b),
corresponding with a TER of around 150 Ohm cm2 (Figure
7a). After 48 hours of Ca2þ treatment occludin is more
continuous at the membrane of differentiated, flattened
cells and this correlated with an even higher TER (þ /
300O cm2). Thus, in vitro keratinocytes are able to form a
functional barrier, the formation of which can be followed
over time.
To examine the role of aPKC in in vitro epidermal barrier
formation, keratinocytes were differentiated in the presence
of an aPKC-specific myristoylated pseudo-substrate inhibitor,
which blocks both aPKCz and aPKCi/l activity. Whereas TER
increased over time in control keratinocytes, little to no
increase in TER was observed in the presence of the aPKC
inhibitor, using three independently isolated keratinoctye
cultures (Figure 7a). Surprisingly, no discernable difference
was osberved in the recruitment of occludin (Figure 7b),
ZO-1, and claudin-1 (results not shown) to intercellular
junctions in the presence of the inhibitor, either in extent
or in its timing.
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Figure 7. Inhibition of aPKC activity in primary keratinocytes. (a) TER
measurement of three independently isolated primary keratinocyte cultures
(passage 5–10). Primary mouse keratinocytes were differentiated with 1.8 mM
Ca2þ for the indicated time points in the absence or presence of 100 mM
aPKCz pseudosubstrate inhibitor. All measurements were carried out in
triplicates. (b) Immunohistochemistry for occludin in primary mouse
keratinocytes differentiated with 1.8 mM Ca2þ for the indicated time points
in the presence or absence of 100 mM of aPKCz pseudosubstrate inhibitor.
Secondary antibodies were labeled with Alexa488. Nuclei were stained using
propidium iodide. White arrowheads in 24 hours: sites where occludin is not
completely continuous at the membrane and shows a more zig-zag pattern.
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The kinase activity and Par3 and Par6 binding domains of aPKC
are necessary for barrier formation
If inhibition of aPKC results in lower trans epithelial
resistance in differentiated keratinocytes than increasing
aPKC function should enhance and accelerate TER build
up. Keratinocytes were transfected with enhanced green
fluorescent protein (eGFP)-tagged wt aPKCz and expression
was detected with antibodies to either GFP or aPKC using
western blot analysis after 48 hours of Ca2þ -induced
differentiation (Figure 8c). Indeed, overexpression of either
wt aPKCz (Figure 8a) or wt aPKCi/l (not shown) increased
TER and accelerated the formation of a barrier when
compared to control keratinocytes.
To assess if kinase activity is indeed important for the role
of aPKC in in vitro epidermal barrier formation assays, a
kinase dead mutant (aPKCzK281M) was expressed in
keratinocytes (Figure 8c). This abrogated the increase in
TER observed in control keratinocytes upon differentiation
(Figure 8a).
Next we wanted to assess if other domains are essential for
aPKC function in keratinocyte barrier formation. Overexpres-
sion of the aPKCz kinase domain alone, which can bind Par3,
also inhibited barrier formation upon keratinocyte differen-
tiation, as measured by TER. The N-terminal region, contain-
ing both the Par6 binding domain and the pseudosubstrate
domain, also blocked to a large extent the increase in trans
epithelial resistance (Figure 8b).
None of the expressed proteins significantly affected
endogenous aPKC or Par3 expression levels either under
low or high calcium conditions (Figure 8c and d). In addition,
using the aPKCi/l antibodies no cross reactivity was found
with the ectopically expressed aPKCz proteins (Figure 8c),
showing the specificity of this antibody for the aPKCi/z
isotype.
DISCUSSION
The epidermis is not considered a classical polarized
epithelial tissue, such as simple epithelia. However, it does
show an overall polarization with each layer having specific
differentiation and junctional markers. How stratifying
epithelia establish polarity and if the classical players, the
polarity complex proteins, play a role in the polarization and
differentiation of these tissues are at present not known. In
this study, we have characterized the localization and
distribution of the Par3/Par6/aPKC polarity complex and of
transmembrane proteins that have the potential to recruit the
complex to junctions in murine skin. Furthermore, we have
shown that endogenous aPKC activity is important for in vitro
barrier formation and thus functional junction assembly.
The partially overlapping distribution of the individual
components in newborn skin and during wound healing
suggests that Par3, Par6, and aPKC are not only incorporated
in a tertiary complex in the skin but are also localized
independently of each other. Thus, these proteins may have
shared but also individual functions in skin. Indeed, distinct
functions have been observed for these proteins in other cell
systems. For example, Par6 and aPKC cooperate in astrocyte
migration (Etienne-Manneville and Hall, 2001) and simple
epithelial apico-basolateral membrane determination (Plant
et al., 2003; Yamanaka et al., 2003), both processes that do
not seem to require Par3 function. In addition, regulation of
NFkB by aPKC appears to be independent of Par3 and Par6
(Moscat et al., 2006). Similarly, our data suggest that Par6 and
aPKC might cooperate during wound healing because they
both show dynamic localization whereas Par3 is unaffected
by wound repair (Figure 7).
Another layer of complexity to the formation and function
of different Par3/Par6/aPKC complexes in cells is formed by
the existence of different isoforms of all three proteins. Par6
consists of three members that are encoded by different
genes, Par6A, B, and C. All three isoforms can interact with
aPKC and GTP-bound Rac, or Cdc42. However, differential
effects on tight junction formation have been observed upon
overexpression of either Par6A and Par6B and this may be
due to a differential interaction with Pals1, which forms part
of the Crb/Patj complex (Gao and Macara, 2004). Three Par3
variants are generated by alternative splicing, the 180, 150,
and 100 kDa forms, the latter of which lacks the aPKC
binding domain (Lin et al., 2000). Keratinocytes express all
three isoforms (Figure 2), albeit that the 180 and 100 kDa
variants are more strongly expressed. Interestingly, we found
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Figure 8. Functional requirement of aPKC in keratinocyte barrier formation.
TER measurement of (a) control (ct) and transfected primary mouse
keratinocytes using the kinase dead mutant eGFP-aPKCz(K281M), the
eGFP-aPKCzwt construct, and (b) control (ct), eGFP-aPKCzkinase domain and
myc-aPKCzIIpCDNA3.1 transfected keratinocytes. After transfection and
plating on filters primary keratinocytes were differentiated with 1.8 mM Ca2þ
for the indicated time points. All measurements were made in duplicates.
(c) Detection of eGFP, aPKC, and aPKCi/l in primary keratinocytes
transfected with different aPKCz mutants and subsequent differentiation with
1.8 mM Ca2þ for 48 hours. (1) untransfected, (2) eGFP-aPKCzwt, (3)
eGFP-PKCzkinase domain, (4) eGFP-aPKCz(K281M) kinase dead,
(5) pcDNA3.1myc-aPKCzII. (d) Expression of Par3 and aPKC in control (1, 2)
and keratinocytes transfected with eGFP-aPKCzwt (3, 4), eGFP-aPKCzkinase
domain (5, 6) undifferentiated (0 hour) or differentiated with 1.8 mM Ca2þ
for 48 hours. Equal amounts of proteins were separated by SDS-PAGE and
immunoblotted for Par3. Actin was used as a loading control. Open arrow:
endogenous aPKC, closed arrow: eGFP-aPKCzkinase domain only.
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a differential distribution in the different layers between an
antibody that can recognize all three isoforms (Figure 1a) and
an antibody recognizing predominantly the 100 kDa isoform.
Thus, although these proteins can form a ternary complex,
they may also function independently of each other,
depending on the isotype expressed and on different
compositions with other interaction partners (Moscat et al.,
2006). The existence of different isoforms and different
complexes in the epidermis and cultured keratinocytes will
therefore require further analysis.
The aPKC family has two isoforms: aPKCz and aPKCi/l,
which are both expressed in epidermis and in cultured
keratinocytes (Figure 4). At present it is not clear if both
aPKCs are functional significant for polarity establishment
and maintenance. Both isoforms can interact with Par3 and
Par6, and are able to rescue tight junction formation.
Moreover, dominant negative aPKCz and aPKCi/l are
both able to interfere with polarity and junction formation
(Suzuki et al., 2001; Mertens et al., 2005). Indeed, we also
found that overexpression of either isoform can enhance
barrier formation in keratinocytes. However, aPKCz
total knockout mice are viable (Leitges et al., 2001)
whereas aPKCi/l inactivation results in an early embryonic
lethal phenotype (Michael Leitges, unpublished results,
Soloff et al., 2004). Interestingly, staining with isotype-
specific antibodies showed close association of aPKCi/l
but not aPKCz with the tight junctions in the granular layer of
the epidermis (Figure 4b), suggesting that this aPKC isotype
may be the most significant for endogenous epidermal tight
junction formation.
An antibody directed against the C-terminus of aPKC,
which recognizes both isotypes of aPKC recognized the
epidermal–dermal junction in basal cells (Figure 1, Tunggal
et al., 2005). This enrichment was not observed with both
specific aPKC antibodies. The latter are raised against the
regulatory N-terminus and the difference may therefore be
due to masking of certain epitopes. Nuclear staining was also
observed for aPKC in the epidermis, as has been described
previously (Perander et al., 2001; White et al., 2002), where it
may regulate downstream targets in mitogenic or metabolic
pathways.
How do Par3 and aPKC and, to a much lesser extent,
Par6 get recruited to sites of cell contact within the
epidermis? A likely candidate is JAM-1, a binding partner
for Par3 (Ebnet et al., 2001), as its localization both in vivo
and in vitro was quite similar to that of Par3. aPKC may
then be recruited by direct binding to Par3. Other candidates
are Crb2 and Crb3, which can recruit Par6 directly or
by associating with the Par6 binding molecule Pals (Hurd
et al., 2003; Lemmers et al., 2004). In simple epithelial
Crb3 has been implicated in tight junction formation. This
may be different in newborn murine epidermis as Crb3
localization is mostly cytoplasmic, with some enrichment at
membrane in the granular layer. Comparatively, Crb2 is
strongly enriched at sites of cell–cell contact in the granular
layer, and may be more important for proper tight junction
formation in the epidermis and recruitment of Par6 to the
cell membrane.
To measure in vitro barrier function over time in primary
keratinocytes we adapted an assay often used for simple
epithelial cells, which measures TER. To our knowledge this
is the first non-invasive assay for primary keratinocytes in
which in vitro differentiation of keratinocytes can be directly
coupled to barrier formation. Using this assay as a read-out,
endogenous aPKC activity was indeed found to be crucial for
barrier build up in primary mouse keratinocytes (Figures 7
and 8). Therefore, similar to simple epithelia (Suzuki et al.,
2001), aPKC is also crucial for the formation of functional
tight junctions in stratifying epithelia. A similar result was
recently shown for T-lymphoma invasion and metastasis
(TIAM)-1, an exchange factor for the small GTPase Rac
(Mertens et al., 2005). Nevertheless, aPKC activity in
keratinocytes did not appear to be crucial for the recruitment
of tight junctional markers to sites of cell–cell contact (Figure
7b). This is in agreement with the in vivo situation, in which
both ZO-1, claudin-1, but also phospho-aPKC, are enriched
at the membrane already in the spinous layers, where
there are no functional tight junctions (Furuse et al., 2002;
Tunggal et al., 2005). This situation may thus be analogous
to simple epithelia where aPKC was found to be one of
the last components recruited to junctions and important for
the transition of spot-like junctions to belt-like junctions
(Suzuki et al., 2001).
How than does aPKC regulate the formation of functional
tight junctions? One possibility is that it may regulate the
formation of functional tight junctional strands by claudins
and ZO-1 (Umeda et al., 2006), by direct or indirect
phosphorylation of tight junctional components by aPKC. It
has already been shown that phosphorylation of tight
junctional components can regulate permeability (Yamauchi
et al., 2004). In the epidermis such an activation step must
only occur in the stratum granulosum of the epidermis and
must be regulated by as yet unknown mechanisms as active
aPKC is already recruited to the membrane in lower layers
(Tunggal et al., 2005).
Overexpression of the N-terminal domain of aPKCz
interfered with barrier formation (Figure 7b), similar to
what was found for the N-terminal variant of aPKCz
in simple epithelial cells (Parkinson et al., 2004). Next to
the pseudosubstrate domain, this protein also contains the
Par6 binding region. As such, it could inhibit both
endogenous aPKCz and aPKCi/l activity by either inhibi-
ting their kinase activity or by recruiting endogenous Par6
away from the complexes necessary for tight junction
formation.
Surprisingly, the C-terminus containing only the kinase
domain and the Par3 binding region also interfered with
keratinocyte barrier formation. A similar aPKCz isoform,
aPKMz, exists in vivo, owing to an alternative brain-specific
promotor located in an intron (Marshall et al., 2000). This
protein has constitutive kinase activity owing to the lack of
the pseudosubstrate domain and can be recruited to the
membrane via binding to Par3, potentially making it a
dominant active form of aPKC. However, our observation
suggests that regulation of aPKC kinase activity is necessary
for tight junction formation. In addition, aPKC may also
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require interactions with other proteins next to Par3, such as
for example Par6, for functional activity.
Overall, our results show that the polarity Par3/Par6/aPKC
complex components have distinct localization patterns, both
in vivo and in vitro. In addition to a possible common
function, these results suggest that they may also have distinct
roles in epidermal morphogenesis and homeostasis. We also
find that aPKC function is essential for tight junction
formation and barrier formation in keratinocytes and this
may require its interaction with Par3 and Par6.
MATERIALS AND METHODS
Keratinocyte isolation, culture, and transfection
Primary keratinocytes were isolated from the skin of newborn mice
as described (Pasparakis et al., 2002) and cultured on collagen
type-1 (Biochrom, Berlin, Germany) coated dishes in F12,
adenine, DMEM (FAD) medium containing 50 mM Ca2þ in the
absence or presence of mitomycin C-treated 3T3 fibroblasts
(4mg/ml) as feeders. For induction of differentiation and cell contact
formation, keratinocytes were transferred to FAD medium
containing 1.8 mM Ca2þ (calcium switch) and cultured for the
indicated time points. Primary mouse keratinocytes were transfected
using the basic primary endothelial nucleofactor kit (Amaxa,
Cologne, Germany) in combination with program T-27 of the
Nucleofector system (Amaxa). Using this method a transfection
efficiency of 40–60% was achieved. The following aPKCz constructs
were used in transfection: eGFP-aPKCzwt, eGFP-aPKCzK281M
(kinase dead, mutation in ATP binding site), eGFPaPKCz kinase
domain, myc-aPKCzIIpcDNA3.1 and eGFP-aPKCi/lwt have all been
described (Perander et al., 2001; Mostafavi-Pour et al., 2003;
Parkinson et al., 2004).
RT-PCR analysis
RNA was isolated from murine newborn skin biopsies, epidermis,
dermis, and isolated murine primary fibroblasts and keratinocytes
using Trifast solution (Peqlab, Erlangen, Germany). The epidermis
was separated from the dermis after skin of newborns was floated for
20 minutes at 41C on 0.5 M ammonium thiocyanate in phosphate
buffer (0.1 M Na2HPO4, 0.1 M KH2PO4 pH 6.8). First strand cDNA
synthesis was performed using superscript reverse transcriptase
(Invitrogen, Karlsruhe, Germany) and oligo(dT) nucleotides accord-
ing to the manual. RT-PCR was carried out as described (Tunggal
et al., 2005) using the following primers: mouse PKCi/l (acc. no.
NM008850) 50-CACTTTGAGCCTTCCATCTCC-30 (203–223 bp, cod-
ing sequence) and 50-GTGACCAGCTTGTGGCACTTC-30 (605–625 bp,
coding sequence); mouse PKCz (acc. no. NM008860) 50-GCGTGGA
TGCCATGACAACAT-30 (112–132 bp, coding sequence); and 50-GG
CTCTTGGGAAGGCATGACA-30 (581–601 bp, coding sequence).
Wound healing experiments
C57/Bl6 (6–8 weeks old) mice were anesthetized with a single
intraperitoneal injection of ketamine/xylazine. The back of the
animals was shaved and the skin cleaned with 70% ethanol. Two
full-thickness excisional wounds (4 mm diameter) were generated on
the back of each animal by excising skin and panniculus carnosum
as described (Werner et al., 1994). The wounds were allowed to dry
to form a scab. Animals were killed at different time points
post-wounding and the complete wounds including the epithelial
margins were isolated, embedded in OCT (Shandon, Pittsburg, PA),
and stored at 801C. Sections taken from the center of the wound
were used in immunohistochemistry and for hematoxylin/eosin
(Shandon) staining. Two independent sets of wound healing were
analyzed. All animal protocols were approved by the local
veterinary authorities.
Antibodies
Antibodies specific for aPKCz or aPKCi/l were raised in rabbits by
injection of the following specific peptides: aPKCz amino acid
185–244: MDSVMPSQEPPVDGKNDGVDLPSEETDGIAYISSSRKHD-
NIKDDSE DLKPVIDGVDGIKISQGLGL and aPKCi/l amino acid
184–234: SLPPEPMMPMDQTMHPDHTQTVIPYNPSSHESLDQVGEE-
KEAMNTRESGKASSSLGL.
The following antibodies were used rabbit polyclonal antibodies
against all isoforms of Par3 (Upstate, Hamburg, Germany), Par3
(recognizing preferentially the 100 kDa form, (Vogelmann and
Nelson, 2005)), aPKC (Santa-Cruz, Heidelberg, Germany), phosho-
aPKC (Cell Signaling, Frankfurt, Germany, it should be noted that
later batches of this antibody failed to show membrane staining
either in immunohistochemistry or immunofluorescence and could
therefore not be used in subsequent analysis), Crb2 and Crb3
(Lemmers et al., 2004) and JAM-1 (a gift of Dr Klaus Ebnet), and goat
antibodies to Par6 (N-18, Santa-Cruz) or JAM-1 (R&D system,
Minneapolis, MN), rat monoclonal anti-ZO-1 R26.4 (Anderson
et al., 1988, DSHB, University of Iowa), and mouse mAbs against
actin (ICN, Heidelberg, Germany), Rac (Sigma, St Louis, MO), or
3E1-GFP (Invitrogen).
Immunohistochemistry and immunofluorescence
Immunohistochemistry was performed on cryosections (6 mm) and
were fixed with 4% paraformaldehyde or methanol. For immuno-
fluorescence keratinocytes were cultured on collagen coated cover-
slips before fixation with methanol. Cells and tissues were blocked in
PBSþ þcontaining 1% BSA, 5% normal goat serum, and 0.02%
Tween-20, after which cells were incubated with the appropriate
primary antibody in blocking buffer followed by secondary
antibodies coupled to Alexa 488 or Alexa 594 (Invitrogen). For
cryosections nuclei were counterstained using propidium idodide
(Sigma-Aldrich, Taufkirchen, Germany). Photos were taken with a
NIKON Eclipse E800 microscope equipped with a NIKON
DMZ1200 camera or a LEICA confocal microscope.
Western blot analysis
Primary keratinocytes of newborn mice (passage 3–9) were washed
with ice-cold PBS containing 1 mM orthovanadate and were lysed at
41C in 1% Nonidet P-40 buffer (10 mM Tris/HCl (pH7.5), 140 mM
NaCl, 1 mM orthovanadate, 2 mM phenylmethylsulphonyl fluoride,
5 mM EDTA, 50 mM NaF, and protease inhibitor cocktail (Sigma)).
After 15 minutes at 41C, cells were scraped off and nuclei pelleted by
centrifugation. Protein levels were determined using Bradford
reagent (Biorad, Munich, Germany). Equal amounts of total
protein were separated by SDS-PAGE using NuPage 4–12% gradient
Bis–Tris Gels (Invitrogen), transferred to nitrocellulose (G&E, Frei-
burg, Germany), and probed with the appropriate antibodies.
Experiments assessing the regulation of expression by Ca2þ -
concentrations were performed at least 3x using different batches
of primary keratinocytes.
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TER measurement
Mouse primary keratinocytes, varying between passage 2–8, were plated
directly or after transfection in a confluent manner onto polycarbonate
Transwell filters (0.4mm pore size, 12mm diameter, Millipore). TER was
measured at different time points with a MillicellERS Voltometer
(Millipore, Eschborn, Germany) after calcium switch and shortly before
(T¼ 0). TER values were corrected by subtracting the blank value (no
cells), and were expressed in ohm cm2. Transfection experiments
were repeated at least twice for each construct using independently
isolated primary mouse keratinocyte cultures.
Inhibition of PKCf activity
For inhibition of aPKC activity, primary murine keratinocytes were
transferred to FAD medium containing 1.8 mM Ca2þ and 100 nM
myristoylated PKCz pseudosubstrate inhibitor (Merck Biosciences,
Bad Soolen, Germany) and grown for the indicated time points. The
medium with fresh inhibitor was changed every 12 hours to ensure
activity of the inhibitor. TER was measured at the indicated time
points during incubation whereas immunohistochemistry was
performed as described after treatment for the indicated time.
Inhibition experiments were repeated four times using independently
isolated primary keratinocyte cultures.
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